Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | GERN Geron Corporation | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.30 -1.5% | $15.06 -2.0% |
| StockIQ Score | 47D+ Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 23F | 13F |
| Fundamental | 46D+ | 35F |
| Growth | 66B- | 50C- |
| Fair Value | 50C- | 38F |
| News | 80A- | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Geron Corporation outperforms Ascentage Pharma in most categories. Its investor score (50 vs. 37) and growth score (66 vs. 50) are notably stronger, reflecting better investor confidence and growth potential. Geron also has a higher fundamental score (46 vs. 35), while Ascentage Pharma’s technical score (18 vs. 42) and overall rating ("WEAK" vs. "MODERATE") lag behind. Valuation scores are equal at 50.